---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-025639"
form_type: "8-K"
ticker: "PETV"
cik: "0001512922"
company_name: "PetVivo Holdings, Inc."
filed_at: "2024-06-28T23:59:59+00:00"
generated_at: "2026-06-01T00:33:15.641314+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# PetVivo FY2024 revenue up 6% to $969K; net loss widens to $11.0M; FY2025 guidance $1.5-$2.0M

## Summary
- Revenue $969K (+6% YoY); gross margin 76.3% (+40 bps).
- Net loss $11.0M ($0.78/sh) vs $8.7M ($0.85/sh) prior year; cash $87K at year-end.
- Subsequent to year-end, raised $1.8M in net proceeds; guides FY2025 revenue $1.5-$2.0M.
- Spryng distributed to >700 clinics, >6,000 syringes; added distributor Covetrus.

## SEC filing metadata
- accession: 0001493152-24-025639
- form_type: 8-K
- ticker: PETV
- cik: 0001512922
- company_name: PetVivo Holdings, Inc.
- filed_at: 2024-06-28T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1512922/000149315224025639/0001493152-24-025639-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1512922/000149315224025639/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-025639
- JSON: https://secwatch.observer/filing/0001493152-24-025639.json
- Plain text: https://secwatch.observer/filing/0001493152-24-025639.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.